- Home
- ELDN vs VLN Comparison
ELDN vs VLN Comparison
Compare ELDN & VLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- VLN
- Stock Information
- Founded
- ELDN 2004
- VLN 2006
- Country
- ELDN United States
- VLN Israel
- Employees
- ELDN N/A
- VLN N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- VLN Semiconductors
- Sector
- ELDN Health Care
- VLN Technology
- Exchange
- ELDN Nasdaq
- VLN Nasdaq
- Market Cap
- ELDN 239.6M
- VLN 208.5M
- IPO Year
- ELDN N/A
- VLN N/A
- Fundamental
- Price
- ELDN $4.34
- VLN $1.84
- Analyst Decision
- ELDN Strong Buy
- VLN Strong Buy
- Analyst Count
- ELDN 1
- VLN 1
- Target Price
- ELDN $16.00
- VLN $4.00
- AVG Volume (30 Days)
- ELDN 553.2K
- VLN 807.9K
- Earning Date
- ELDN 11-12-2024
- VLN 11-06-2024
- Dividend Yield
- ELDN N/A
- VLN N/A
- EPS Growth
- ELDN N/A
- VLN N/A
- EPS
- ELDN N/A
- VLN N/A
- Revenue
- ELDN N/A
- VLN $63,134,000.00
- Revenue This Year
- ELDN N/A
- VLN N/A
- Revenue Next Year
- ELDN N/A
- VLN $28.20
- P/E Ratio
- ELDN N/A
- VLN N/A
- Revenue Growth
- ELDN N/A
- VLN N/A
- 52 Week Low
- ELDN $1.43
- VLN $1.67
- 52 Week High
- ELDN $5.54
- VLN $3.39
- Technical
- Relative Strength Index (RSI)
- ELDN 42.46
- VLN 40.01
- Support Level
- ELDN $4.32
- VLN $1.99
- Resistance Level
- ELDN $4.76
- VLN $2.29
- Average True Range (ATR)
- ELDN 0.39
- VLN 0.18
- MACD
- ELDN -0.09
- VLN -0.03
- Stochastic Oscillator
- ELDN 2.65
- VLN 2.36
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About VLN Valens Semiconductor Ltd.
Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Audio-Video, which includes the company's HDBaseT solutions for the Audio-Video market deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.